Valeo Financial Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-140
Closed -$14K 1799
2019
Q3
$14K Sell
140
-706
-83% -$67.1K ﹤0.01% 955
2019
Q2
$78K Buy
846
+495
+141% +$47K 0.01% 483
2019
Q1
$33K Sell
351
-1,608
-82% -$141K ﹤0.01% 657
2018
Q4
$126K Buy
1,959
+939
+92% +$69.3K 0.02% 336
2018
Q3
$73K Sell
1,020
-2,002
-66% -$177K 0.01% 472
2018
Q2
$278K Buy
3,022
+566
+23% +$47K 0.04% 240
2018
Q1
$219K Buy
2,456
+165
+7% +$15.8K 0.04% 248
2017
Q4
$239K Buy
2,291
+552
+32% +$62.3K 0.04% 219
2017
Q3
$254K Buy
+1,739
New +$237K 0.06% 183

Other funds holding CELG

Valeo Financial Advisors's CELG Position: Q4 2019 in Review

Valeo Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 140 shares — an estimated $14K sold.

Valeo Financial Advisors first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $278K in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Valeo Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Valeo Financial Advisors sold 140 Celgene Corp shares in Q4 2019, an estimated $14K.
  • Valeo Financial Advisors first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Valeo Financial Advisors's Celgene Corp position peaked at $278K in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Valeo Financial Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.